Financing channel feed

Odyssey pulls back from IPO plans as pub­lic mar­kets re­main frozen

Last month
Startups

Up­dat­ed: Oma­da Health rose 21% in its pub­lic mar­ket de­but

Last month
Health Tech

At a cross­roads, biotechs are pass­ing on re­verse merg­ers in 2025

Last month
Deals

Oma­da Health is go­ing pub­lic at a $1.1B val­u­a­tion

Last month
Health Tech

Ex­clu­sive: Al­lay reach­es $57.5M Se­ries D mile­stone for post-sur­gi­cal pain drug

Last month
Startups

Ex­clu­sive: Tech VC Am­pli­fy rais­es $200M for first biotech fund, hires El­liot Her­sh­berg as new part­ner

Last month
Startups

Ex­clu­sive: Cin­Dome gets an­oth­er $40M to ad­vance gas­tro­pare­sis drug

Last month
Startups

Canid rais­es $10M to man­age vac­cines for pe­di­a­tri­cians

Last month
Startups
Health Tech

Ko­re­an start­up Curo­gen seeks glob­al ex­pan­sion, new fund­ing to back au­toim­mune drugs

Last month
Startups

As a chal­leng­ing first half nears a close, bio­phar­ma un­cer­tain­ty per­sists

Last month
Deals
Pharma

Ex­clu­sive: Move­ment dis­or­der biotech Vi­ma steps on­to scene with $60M

Last month
Startups

Post-Hoc Live: Is biotech sen­ti­ment re­al­ly as bad as it seems? 

Last month
Deals
Editor's note

Up­dat­ed: MD An­der­son-al­lied in­vest­ment firm tar­gets $250M for sec­ond can­cer biotech fund

Last month
Startups

Brook­lyn Health rais­es $6.5M to stan­dard­ize men­tal health as­sess­ment

Last month
Health Tech

In­vestors pump $130M in­to pro­tein de­grad­er start­up Gly­co­Era

Last month
Startups

Syn­deio de­buts with $90M+ to bring to­geth­er synapse re­pair drugs

Last month

Ex­clu­sive: Toron­to biotech Pro­tein­Qure nears the clin­ic with pep­tide plat­form as it rais­es $11M Se­ries A

Last month

Up­dat­ed: Hinge Health jumped 18% on its first day as the dig­i­tal health IPO mar­ket reawak­ens

Last month
Deals
Health Tech

Hinge Health is go­ing pub­lic on Thurs­day at a $3B val­u­a­tion

Last month
Health Tech

Re­pro­duc­tive health biotech snags $65M to de­vel­op for­mer No­var­tis and Mer­ck KGaA drugs

Last month
Startups

UK biotech Ju­ve­nes­cence tar­gets $150M+ for 'healthy lifes­pan' drug can­di­dates

Last month
Startups

Ex­clu­sive: Op­tura rais­es $6.5M to help eval­u­ate health­care AI pro­grams

Last month
Health Tech

Ex­clu­sive: At-home screen­ing start­up Repe­rio Health rais­es $14M

Last month
Diagnostics
Health Tech

Ex­clu­sive: Cell­Cen­tric col­lects $120M to treat mul­ti­ple myelo­ma with a cap­sule

Last month
Startups
First page Previous page 12345 Next page Last page
A service from the Financial Times